Joint letter to Secretary of State Blinken, Commerce Secretary Raimondo, USTR Ambassador Tai and White House Chief of Staff Jeffrey Zients on the WTO TRIPS Waiver and upcoming WTO 13th Ministerial Conference
February 21, 2024
The companies and workers represented by the undersigned organizations stepped up to combat the COVID-19 pandemic, investing in and creating hundreds of partnerships at an unprecedented speed and scale to leverage U.S. innovation and manufacturing capacity to create, produce and distribute critical products needed to save lives. U.S. industry has partnered with associations, governments, academia, civil society and international organizations to increase supply and delivery of those products to those most in need. These efforts helped bring the pandemic phase of COVID-19 in the U.S. and around the world to an end....
Download Full Comments Below
Joint letter to Secretary of State Blinken, Commerce Secretary Raimondo, USTR Ambassador Tai and White House Chief of Staff Jeffrey Zients on the WTO TRIPS Waiver and upcoming WTO 13th Ministerial Conference (February 21, 2024)
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.
The companies and workers represented by the undersigned organizations stepped up to combat the COVID-19 pandemic, investing in and creating hundreds of partnerships at an unprecedented speed and scale to leverage U.S. innovation and manufacturing capacity to create, produce and distribute critical products needed to save lives. U.S. industry has partnered with associations, governments, academia, civil society and international organizations to increase supply and delivery of those products to those most in need. These efforts helped bring the pandemic phase of COVID-19 in the U.S. and around the world to an end....